METHYLLYCACONITINE - A NOVEL NICOTINIC ANTAGONIST

被引：73

作者：

DRASDO, A

CAULFIELD, M

BERTRAND, D

BERTRAND, S

WONNACOTT, S

机构：

[1] CTR MED UNIV GENEVA,DEPT PHYSIOL,CH-1211 GENEVA 4,SWITZERLAND

[2] UNIV LONDON UNIV COLL,DEPT PHARMACOL,LONDON WC1E 6BT,ENGLAND

来源：

MOLECULAR AND CELLULAR NEUROSCIENCE | 1992年 / 3卷 / 03期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/1044-7431(92)90043-2

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Methyllycaconitine (MLA), a natural toxin from Delphinium seeds, was investigated for its ability to antagonize nicotinic responses in several preparations representing different subtypes of neuronal nicotinic acetylcholine receptor. A presynaptic nicotinic receptor mediating dopamine release from rat striatal synaptosomes was blocked by 10 μM MLA, in good agreement with its Ki of 4 μM for inhibition of [3H]nicotine binding to striatal membranes. Nicotinic responses in rat superior cervical ganglia were similarly blocked by MLA, and this inhibition was readily reversible. Functional expression of the chick α3nα1 and α4nα1 receptor subtypes in Xenopus oocytes confirmed that MLA is a nicotinic antagonist at both receptor subtypes, with IC50 values of 0.08 and 0.65 μM, respectively. Inhibition by MLA was voltage independent and competitive with agonist concentration. Thus MLA is a useful addition to the nicotinic pharmacopoeia. © 1992.

引用

页码：237 / 243

页数：7

共 34 条

[1]

ALKONDON M, 1992, IN PRESS MOL PHARM, V41

[2] ACTIVATION AND BLOCKING OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR RECONSTITUTED IN XENOPUS OOCYTES [J].